Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Two genes co-operate to cause aggressive leukaemia

03.11.2009
Two genes, each one of which is known to cause cancer on its own, together can lead to aggressive leukaemia. This is the conclusion from new research carried out on gene-modified mice at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery has surprised scientists, and may lead to new treatments.

The two genes are often present in mutated form in acute leukaemias, but the mutations rarely occur together. Scientists have previously believed that the two mutated genes have exactly the same function: each one alone will lead to increased activity of a carcinogenic protein known as "RAS". This protein, in turn, causes blood cells to proliferate more rapidly.

"This is a surprising discovery that suggests that there is a mechanism behind the development of cancer that has not yet been recognised. It opens the way for new methods of fighting blood cancer cells with NF1 mutations", says Associate professor Martin Bergö, who leads the research at the Wallenberg Laboratory at the Sahlgrenska Academy.

One of the genes codes for the RAS protein, which is a known accelerator for cell proliferation in several forms of cancer. The other gene codes for a protein known as "NF1", which is known to reduce the activity of the RAS protein.

The research group at the Sahlgrenska Academy has previously used two different types of mouse models, one of them with the RAS-mutation and the other with the NF1-mutation. Both mutations individually cause a slowly progressing leukaemia to develop in the mice. The research group has now combined the two animal models and shown that a very aggressive form of acute leukaemia develops in mice with mutations in both genes.

"The corresponding increase in the RAS signalling cannot explain the severe increase in disease aggressiveness, and this means that the NF1 protein may play a different role in the development of the leukaemia than we originally thought and may not involve the RAS protein at all. The discovery opens the possibility of developing new treatments for patients who have mutations in NF1", says Martin Bergö.

The research group is now collaborating with another research group at the Sahlgrenska Academy, investigating the role that the NF1 protein plays, and how these new results can lead to new treatment strategies.

LEUKAEMIA
Around 900 people in Sweden are diagnosed with leukaemia each year. Leukaemias are diseases of the blood that involve the formation of large quantities of white blood cells. The leukaemia cells often invade the liver, spleen and lymph nodes, leading to a seriously impaired immune defence. Considerable progress has been made in research into leukaemia during recent decades, both with respect to treatment and classification, but the fundamental processes remain partially unknown.
For more information, contact:
Associate professor: Martin Bergö, telephone: +46 31 342 7858, martin.bergo@wlab.se.se
Journal: Blood
Title of the article: NF1 deficiency co-operates with oncogenic K-RAS to induced acute myeloid leukemia in mice

Authors: Briony A. Cutts, Anna-Karin M. Sjögren, Karin M.E. Andersson, Annika M. Wahlström, Christin Karlsson, Birgitta Swolin and Martin O. Bergö

Press information: elin.lindstrom@sahlgrenska.gu.se
+46 (0)31 7863869
Elin Lindström Claessen

Helena Aaberg | idw
Further information:
http://www.gu.se/
http://www.sahlgrenska.gu.se/english/news_and_events/news/News_Detail/Two_genes_co-operate_to_cause_aggressive_leukaemia_.cid900483

Further reports about: NF1 RAS protein Ras Sahlgrenska blood cell lymph node mouse model white blood cell

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>